|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-4-28
|
|
pubmed:abstractText |
Carcinoembryonic antigen (CEA) flare may have a favourable response to chemotherapy, but its impact on survival is unknown. This study aimed to evaluate the incidence of CEA flare and its impact on objective response rate (ORR), progression-free survival (PFS) and overall survival (OS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1013-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19861580-Adenocarcinoma,
pubmed-meshheading:19861580-Adult,
pubmed-meshheading:19861580-Aged,
pubmed-meshheading:19861580-Aged, 80 and over,
pubmed-meshheading:19861580-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19861580-Camptothecin,
pubmed-meshheading:19861580-Carcinoembryonic Antigen,
pubmed-meshheading:19861580-Colorectal Neoplasms,
pubmed-meshheading:19861580-Female,
pubmed-meshheading:19861580-Follow-Up Studies,
pubmed-meshheading:19861580-Humans,
pubmed-meshheading:19861580-Male,
pubmed-meshheading:19861580-Middle Aged,
pubmed-meshheading:19861580-Neoplasm Metastasis,
pubmed-meshheading:19861580-Neoplasm Staging,
pubmed-meshheading:19861580-Organoplatinum Compounds,
pubmed-meshheading:19861580-Prognosis,
pubmed-meshheading:19861580-Survival Rate,
pubmed-meshheading:19861580-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy.
|
|
pubmed:affiliation |
Department of Medicine, Royal Marsden Hospital, London and Surrey, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
